Arthur Sands
Net worth: 16 M $ as of 2026-05-30
Net worth: 16 M $ as of 2026-05-30
Arthur T.
Sands was the founder of Lexicon Pharmaceuticals, Inc., founded in 1995, where the titles held included President, Chief Executive Officer & Director from 2011 to 2014.
Current jobs include President, Chief Executive Officer & Director at Nurix Therapeutics, Inc. since 2014, with the CEO title starting in 2020, and Director at Biotechnology Innovation Organization.
Former job includes Director at Symphony Icon, Inc. Education history includes undergraduate studies at Yale University and graduate and doctorate degrees from Baylor College of Medicine.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-03-19 | 908,333 ( 0.88% ) | 16 M $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| NURIX THERAPEUTICS, INC. | Chief Executive Officer | 2014-09-17 |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Director/Board Member | - |
| Companies | Position | End |
|---|---|---|
| LEXICON PHARMACEUTICALS, INC. | Founder | 2014-07-06 |
Symphony Icon, Inc.
Symphony Icon, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Director/Board Member | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 6 |
|---|---|
Lexicon Pharmaceuticals, Inc.
Lexicon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Nurix Therapeutics, Inc.
Nurix Therapeutics, Inc. BiotechnologyHealth Technology Operates as a a clinical stage biopharmaceutical company that discovers, develops and commercializes oral, small molecule therapies for the treatment of cancer & immune disorders | Health Technology |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Baylor College of Medicine
Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Symphony Icon, Inc.
Symphony Icon, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Select your edition
All financial news and data tailored to specific country editions